Symbol="AGIO"
AssetType="Common Stock"
Name="Agios Pharm"
Description="Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts."
CIK="1439222"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="88 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1520011000"
EBITDA="-367183008"
PERatio="None"
PEGRatio="0"
BookValue="17.3"
DividendPerShare="0"
DividendYield="0"
EPS="-3.79"
RevenuePerShareTTM="0.365"
ProfitMargin="0"
OperatingMarginTTM="-18.59"
ReturnOnAssetsTTM="-0.2"
ReturnOnEquityTTM="-0.201"
RevenueTTM="20147000"
GrossProfitTTM="12536000"
DilutedEPSTTM="-3.79"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.202"
AnalystTargetPrice="38.83"
TrailingPE="-"
ForwardPE="2.466"
PriceToSalesRatioTTM="164.39"
PriceToBookRatio="1.623"
EVToRevenue="107.31"
EVToEBITDA="-2.763"
Beta="0.953"
num_52WeekHigh="34.76"
num_52WeekLow="21.07"
num_50DayMovingAverage="26.9"
num_200DayMovingAverage="26.45"
SharesOutstanding="55581000"
DividendDate="None"
ExDividendDate="None"
symbol="AGIO"
open="26.93"
high="27.34"
low="26.84"
price="27.27"
volume="348302.00"
latest_trading_day="2023-08-30"
previous_close="27.01"
change="0.26"
change_percent="0.9626%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="419746"
Change_recent_avg="0.06"
Delta_recent_avg="0.93"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="1117"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="627"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_positive_thumbnail_id_2="646"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
